Refractory, metastatic squamous cell Non-small cell lung cancer

DrugDrug NameDrug Description
DB08916AfatinibAn antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy.
DrugDrug NamePhaseStatusCount